GOLDEN, Colo., June 29, 2017 /PRNewswire/ — Bio2 Medical today announced the results of the Angel® Catheter pivotal study, “Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients,” published in the Journal of Vascular and Interventional Radiology (JVIR). The […]
Peripheral/Endo
Royal Philips Electronics N.V. (PHG) Slams Down $2.16 Billion for Spectranetics (SPNC)
6/28/2017 5:53:44 AM Philips To Acquire The Spectranetics Corporation To Accelerate Expansion In Image-Guided Therapy Devices To Treat Cardiac And Peripheral Vascular Disease AMSTERDAM, the Netherlands and COLORADO SPRINGS, Colo., June 28, 2017 (GLOBE NEWSWIRE) — Royal Philips(NYSE:PHG) (AEX:PHIA), a global leader in health technology, and The Spectranetics Corporation (NASDAQ:SPNC), a U.S.-based global […]
Heart Endovascular & Rhythm of Texas Begins First Commercial, FDA-Cleared, In-Patient Use of DABRA™ to Treat Peripheral Artery Disease
SAN ANTONIO–(BUSINESS WIRE)–Today, the Heart Endovascular & Rhythm of Texas announced its latest collaboration with Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, to use its groundbreaking DABRA™ System for the treatment of Peripheral Artery Disease (PAD) in order to combat the growing rise of diabetic […]
Shockwave Medical Announces U.S. Commercial Availability Of Lithoplasty System And Enrollment Of First Patient In DISRUPT PAD III Global Clinical T
FREMONT, Calif.–(BUSINESS WIRE)–Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced two milestones for its Lithoplasty® System for the treatment of calcified plaque in patients with peripheral artery disease (PAD): enrollment of the first patient in the global DISRUPT PAD III clinical trial at the Medical […]
TVA Medical Release: Study Published In Prominent Journal Supports Use Of Innovative Endovascular Hemodialysis Access Technology
AUSTIN, Texas, June 15, 2017/PRNewswire/ — TVA Medical, Inc. today announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQTM endoAVF System. The 12-month data published online in the American Journal of Kidney Diseases (AJKD), the official journal of the National Kidney Foundation, […]
San Francisco Surgeon Dr. Timothy Chuter Receives the 2017 Jacobson Innovation Award of the American College of Surgeons
Newswise — CHICAGO : The 2017 Jacobson Innovation Award of the American College of Surgeons (ACS) was presented to Timothy A.M. Chuter, BM BS, DM, FACS, at a dinner held in his honor in Chicago, Ill. Dr. Chuter is a professor of surgery at the University of California, San Francisco […]
Distinguished Vascular Surgeon, Douglas Paget, MD, FACS, RVT will be Spotlighted in The Leading Physicians of the World
PR NewsChannel: The International Association of HealthCare Professionals is pleased to welcome Douglas Paget, MD, FACS, RVT, Vascular Surgeon to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Paget is a highly trained and qualified surgeon with an extensive expertise in all facets […]
Europe’s LimFlow Hires a COO and Opens Bay Area Office
LimFlow Expands Senior Management Team And Opens Silicon Valley Office PARIS–(BUSINESS WIRE)–LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), a severe form of peripheral artery disease (PAD), today announced the expansion of the company’s senior management team. Sophie Humbert, PhD, has been appointed […]
Cagent Vascular Completes Enrollment of PRELUDE Study Using Serranator Device
WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular, a developer of next generation technology for vessel dilatation in cardiovascular disease interventions, including the FDA 510(k) cleared Serranator® Alto PTA Serration Balloon Catheter, announces the completion of enrollment in the First-in-Human PRELUDE Study. The purpose of this prospective, single-arm, multicenter feasibility study is to show […]
Avera Names Myles Greenberg, MD, as CEO of Alucent Medical
SIOUX FALLS, S.D.–(BUSINESS WIRE)–Myles D. Greenberg, MD, was named President and CEO of Alucent Medical, Inc., a new company licensed to develop a novel drug/device combination therapy for the treatment of peripheral vascular disease (PVD). The treatment, Natural Vascular Scaffolding (NVS)TM, has recently gained FDA approval to move forward with […]



